Fentanyl transdermal therapeutic system
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedAbout Fentanyl transdermal therapeutic system
Fentanyl transdermal therapeutic system is a approved stage product being developed by Johnson & Johnson for Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT00523887. Target conditions include Pain.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00523887 | Approved | Completed |
Competing Products
20 competing products in Pain